Laia Bernad Rosa

Graduated in Biotechnology at the Autonomous University of Barcelona and with great interest and vocation for virology, Laia has done internships during her undergraduate studies in the immunopathology group of the IGTP. Subsequently, she continued her training in the group of Infectious Pathologies and Antimicrobials at IMIM. Finally, she completed her academic training by completing the Master's degree in Virology at the Complutense University of Madrid, developing her Master's thesis at CISA, focused on the study of 3 vaccine candidates for bluetongue virus. Currently, she is part of the VIRIEVAC team at IrsiCaixa.